Significance of new lung infiltrates in outpatients after lung and heart-lung transplantation

Transplant Infectious Disease

Volumn 16, Issue 3, 2014, Pages 359-368

  Diaz Ravetllat V ^a   Greer, M ^b   Haverich, A ^b   Warnecke, G ^b   Dierich, M ^b   Welte, T ^b   Gottlieb, J ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Bronchoalveolar lavage; Bronchoscopy; Immunocompromised host; Lung transplantation; Pneumonia

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BRONCHOSCOPY; CHRONIC LUNG ALLOGRAFT DYSFUNCTION; FEMALE; FOLLOW UP; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HEART LUNG TRANSPLANTATION; HUMAN; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; OVERALL SURVIVAL; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; CAUSE OF DEATH; LUNG; LUNG DISEASES; LUNG TRANSPLANTATION; MIDDLE AGED; PATHOLOGY; RISK FACTOR;

ADULT; CAUSE OF DEATH; FEMALE; HEART-LUNG TRANSPLANTATION; HUMANS; LUNG; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84901985735     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12209     Document Type: Article

References (33)

1. Dauber JH, Paradis IL, Dummer JS. Infectious complications in pulmonary allograft recipients. Clin Chest Med 1990; 11 (2): 291-308.
2. Alexander BD, Tapson VF. Infectious complications of lung transplantation. Transpl Infect Dis 2001; 3 (3): 128-137.
3. Martinu T, Chen DF, Palmer SM. Acute rejection and humoral sensitization in lung transplant recipients. Proc Am Thorac Soc 2009; 6 (1): 54-65.
4. Ashrafian H, Davey P. Is amiodarone an underrecognized cause of acute respiratory failure in the ICU? Chest 2001; 120 (1): 275-282.
5. Seethamraju H, Kaleekal TS, Bag R. Pulmonary toxicity of sirolimus in lung transplant patients. Chest 2003; 124 (4 Meeting Abstracts): 101S.
6. Okuno SH, Frytak S. Mitomycin lung toxicity. Acute and chronic phases. Am J Clin Oncol 1997; 20 (3): 282-284.
7. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26 (2): 319-338.
8. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21 (3): 297-310.
9. Woodhead MA, Torres A. Definition and classification of community-acquired and nosocomial pneumonias. In: Torres A, Woodhead MA, eds. Pneumonia. Sheffield, UK: European Respiratory Society Journals Ltd., 1997: 1-12.
10. Murray PRBE, Pfaller MA, Tenover FC, Yolken RH. Manual of Clinical Microbiology (6th edn). Washington, DC: American Society for Microbiology, 1995.
11. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46 (12): 1813-1821.
12. Kothe H, Dalhoff K. Pneumonia in the immunocompromised patient. European Respiratory Monograph: Respiratory Emergencies: European Respiratory Society Journals Ltd, 2006: 200-213.
13. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007; 26 (12): 1229-1242.
14. Gottlieb J, Mattner F, Weissbrodt H, et al. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis. Respir Med 2009; 103 (5): 743-749.
15. Collins J. Imaging of the chest after lung transplantation. J Thorac Imaging 2002; 17 (2): 102-112.
16. Aguilar-Guisado M, Givalda J, Ussetti P, et al. Pneumonia after lung transplantation in the RESITRA Cohort: a multicenter prospective study. Am J Transplant 2007; 7 (8): 1989-1996.
17. Remund KF, Best M, Egan JJ. Infections relevant to lung transplantation. Proc Am Thorac Soc 2009; 6 (1): 94-100.
18. Joos L, Chhajed PN, Wallner J, et al. Pulmonary infections diagnosed by BAL: a 12-year experience in 1066 immunocompromised patients. Respir Med 2007; 101 (1): 93-97.
19. Iversen M, Burton CM, Vand S, et al. Aspergillus infection in lung transplant patients: incidence and prognosis. Eur J Clin Microbiol Infect Dis 2007; 26 (12): 879-886.
20. Vos R, Vanaudenaerde BM, De Vleeschauwer SI, et al. Circulating and intrapulmonary C-reactive protein: a predictor of bronchiolitis obliterans syndrome and pulmonary allograft outcome. J Heart Lung Transplant 2009; 28 (8): 799-807.
21. Botha P, Archer L, Anderson RL, et al. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation 2008; 85 (5): 771-774.
22. Gottlieb J, Schulz TF, Welte T, et al. Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study. Transplantation 2009; 87 (10): 1530-1537.
23. Sato M, Waddell TK, Wagnetz U, et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant 2011; 30 (7): 735-742.
24. Angles R, Tenorio L, Bravo C, Teixidor J, Rochera M, de Latorre FJ. [Reimplantation lesion in the postoperative period of lung transplantation. Incidence, predictive factors, prognosis and outcome. The Lung Transplantation Group of Vall d'Hebron University General Hospital.] Med Clin (Barc) 1999; 113 (3): 81-84.
25. Anderson DC, Glazer HS, Semenkovich JW, et al. Lung transplant edema: chest radiography after lung transplantation-the first 10 days. Radiology 1995; 195 (1): 275-281.
26. Oto T, Griffiths AP, Levvey BJ, Williams TJ, Snell GI. Unilateral radiographic abnormalities after bilateral lung transplantation: exclusion from the definition of primary graft dysfunction? J Thorac Cardiovasc Surg 2006; 132 (6): 1441-1446.
27. Paradis IL, Duncan SR, Dauber JH, Yousem S, Hardesty R, Griffith B. Distinguishing between infection, rejection, and the adult respiratory distress syndrome after human lung transplantation. J Heart Lung Transplant 1992; 11 (4 Pt 2): S232-S236.
28. Pickhardt PJ, Siegel MJ, Anderson DC, Hayashi R, DeBaun MR. Chest radiography as a predictor of outcome in posttransplantation lymphoproliferative disorder in lung allograft recipients. AJR Am J Roentgenol 1998; 171 (2): 375-382.
29. Dunagan DP, Baker AM, Hurd DD, Haponik EF. Bronchoscopic evaluation of pulmonary infiltrates following bone marrow transplantation. Chest 1997; 111 (1): 135-141.
30. Guilinger RA, Paradis IL, Dauber JH, et al. The importance of bronchoscopy with transbronchial biopsy and bronchoalveolar lavage in the management of lung transplant recipients. Am J Respir Crit Care Med 1995; 152 (6 Pt 1): 2037-2043.
31. Colombat M, Groussard O, Lautrette A, et al. Analysis of the different histologic lesions observed in transbronchial biopsy for the diagnosis of acute rejection. Clinicopathologic correlations during the first 6 months after lung transplantation. Hum Pathol 2005; 36 (4): 387-394.
32. Stolz D, Stulz A, Muller B, Gratwohl A, Tamm M. BAL neutrophils, serum procalcitonin, and C-reactive protein to predict bacterial infection in the immunocompromised host. Chest 2007; 132 (2): 504-514.
33. Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2006; 174 (5): 566-570.